The European Pharmacopoeia Commission has set the goals of rapidly increasing the number of European Pharmacopoeia monographs, while reducing the time needed to elaborate and revise them. The European Pharmacopoeia Commission, which holds three sessions per year, can in its decisions, add substances to, or delete substances from, the work programme. If the need is expressed, monographs on recent substances still under patent protection can also be included.